Overview

Nedaplatin Combined With Gemcitabine in the Treatment of Recurrent and/or Metastatic Nasopharyngeal Carcinoma : a Single Arm and Phase Ⅱ Clinical Trail

Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this single arm,phase Ⅱ clinical trail is to determine the safety and efficacy of nedaplatin combined with gemcitabine in the treatment of recurrent and metastatic nasopharyngeal carcinoma
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Sun Yat-sen University
Treatments:
Gemcitabine
Nedaplatin
Criteria
Inclusion Criteria:

- biopsy proved nasopharyngeal carcinoma; stage IVc according to Union for International
Cancer Control (UICC) edition VII,or recurrent disease after chemotherapy and/or
radiotherapy; 18 years or older; without other malignancy; proper functioning of the
major organs.

Exclusion Criteria:

- allergic to nedaplatin and/or gemcitabine; female within gestation period or
lactation; patients received drug of other clinical trail within 3 months.